To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among ...

The impact of AI on drug development and compliance is already making waves, and it’s not slowing down. In fact, pharma companies that don’t embrace AI will struggle to remain competitive and ...

However, adopting open-source tools in drug development has brought several challenges. These include: 1. Lack of industry support and documentation ...

From cancer to infectious diseases to neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, there ...

The salient pharmacologic features of the selective serotonin reuptake inhibitors (SSRIs) discovered in the late 1980s included an in vitro ability to inhibit various cytochrome P450 enzymes (CYPs).

A survey of pharmaceutical companies comparing reasons for attrition between 1991 and 2000, expressed as a percentage of all drug projects stopped during clinical development, reveals a large ...

A team of researchers has turned ordinary yeast into tiny, glowing drug factories, creating and testing billions of peptide-based compounds in record time. This green-tech breakthrough could ...

Mathieu Bennet: In B-cell cloning, single-cell isolation occurs at two crucial stages. First, during the initial screening ...

Background and objective Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an ...

Almac Sciences | 5,177 followers on LinkedIn. High quality, on time and full delivery of your outsourced projects | Our aim is to be the leading provider of pharmaceutical development services ...